Related Experiment Video
Updated: Apr 19, 2026
04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
10.5K
[What's new in internal medicine?].
1Clinique de dermatologie, hôpitaux universitaires de Genève, rue Gabriellet Perret-Gentil 4, CH-1211 Genève, Suisse.
Annales De Dermatologie Et De Venereologie
|December 26, 2014
Summary
This review highlights recent advancements in antiphospholipid syndrome, dermatomyositis, systemic sclerosis, and celiac disease for dermatologists. New therapies and diagnostic insights are emerging for these autoimmune conditions.
Area of Science:
- Dermatology
- Immunology
- Internal Medicine
Context:
- Autoimmune diseases present complex challenges for dermatologists, requiring updated knowledge on diagnosis and treatment.
- Antiphospholipid syndrome, dermatomyositis, systemic sclerosis, and celiac disease are increasingly recognized for their dermatological manifestations.
Purpose:
- To provide a comprehensive overview of recent trends and innovations in key autoimmune diseases relevant to dermatological practice.
- To synthesize current research on diagnostic advancements, pathomechanisms, and therapeutic strategies for selected autoimmune conditions.
Summary:
- Antiphospholipid syndrome updates include mTOR pathway involvement in renal disease and diverse therapeutic options like mTOR inhibitors and biologics.
- Dermatomyositis research features new autoantibodies with clinical correlation and genetic predisposition studies.
- Systemic sclerosis shows therapeutic promise with rituximab and stem cell therapies, while celiac disease diagnosis is aided by recognizing cutaneous manifestations.
Impact:
- This review equips dermatologists with the latest information to improve patient care and diagnostic accuracy for autoimmune diseases.
- It facilitates the integration of novel therapeutic approaches and diagnostic biomarkers into clinical practice, enhancing management strategies.
Related Concept Videos
01:14Myocarditis III: Medical Management
331
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
331
01:17Pericarditis III: Medical Management
556
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
556
01:18Endocarditis III: Medical Management
351
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
351
01:26Mitral Stenosis III: Medical Management
488
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
488
01:21Rheumatic Heart Disease III: Medical Management
524
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
524
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
1
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
1